Olinciguat Uses, Dosage, Side Effects and more
Olinciguat is under investigation in clinical trial NCT03892499 (A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers).
Trade Name | Olinciguat |
Generic | Olinciguat |
Olinciguat Other Names | Olinciguat |
Type | |
Formula | C21H16F5N7O3 |
Weight | Average: 509.397 Monoisotopic: 509.123478218 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |